Telehealth Education for Vaccine Hesitancy
What You Need to Know Before You Apply
What is the purpose of this trial?
This study is a 12-18 month behavioral intervention study to assess the impact of enrolling individuals a clinical pharmacist run Telehealth education focused on wellness and preventive health strategies. Individuals will be randomized to either a wellness education only model focusing on nutrition, diabetes, hyperlipidemia and hypertension or a wellness education model with personalized preventative medicine strategies for the patient. All participants will complete individual and group based interventions. Individuals will be recruited from target work industries such as health workers, teachers aides and the food industry. We are recruiting individuals who come from urban, semi-rural or rural communities or have additional social determinants of health that indicate social vulnerability. The primary outcome is willingness to participate in preventative medicine strategies to prevent development of chronic medical conditions. The secondary outcome is barriers to preventive medicine strategies including for chronic preventable disease such as nutrition, hypertension, hyperlipidemia, diabetes and medication compliance.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems to focus on education about vaccines and wellness, so it's unlikely that you would need to change your medication routine.
How does the Telehealth Education for Vaccine Hesitancy treatment differ from other treatments for vaccine hesitancy?
This treatment is unique because it uses telehealth (remote healthcare services) to provide education and support, which can be more accessible and convenient for patients compared to traditional in-person interventions. It combines wellness education with specific vaccination information, potentially addressing both general health concerns and specific vaccine hesitancy in a comprehensive manner.12345
What data supports the effectiveness of the treatment Telehealth Education for Vaccine Hesitancy?
Research shows that telehealth and internet-based education programs can improve health outcomes and user satisfaction in various clinical settings. These programs have been effective in increasing patient engagement and improving practices, suggesting potential benefits for addressing vaccine hesitancy through telehealth education.678910
Who Is on the Research Team?
Sara Al-Dahir, PhD
Principal Investigator
Xavier University of Louisiana.
Klaus Heyer, PhD
Principal Investigator
Nunez Community College
Are You a Good Fit for This Trial?
This trial is for adults aged 18-55 working in high-risk industries like healthcare, education, and food service. Participants should have incomplete COVID-19 or flu vaccinations, speak English, and be able to use telehealth tech. Those with severe allergies to vaccines, certain heart conditions, immunosuppressive diseases, or who've completed their COVID-19 vaccine series can't join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive telehealth interventions focusing on wellness, with one arm also receiving vaccination education and counseling
Follow-up
Participants are monitored for vaccine completion and changes in vaccine hesitancy
What Are the Treatments Tested in This Trial?
Interventions
- Telehealth: Wellness and Vaccination
- TeleHealth: Wellness Only
Find a Clinic Near You
Who Is Running the Clinical Trial?
Xavier University of Louisiana.
Lead Sponsor